France will take a stake in Sanofi's Opella through the Public Investment Bank (BPI), finance minister Antoine Armand said on ...

The proposed sale turned into a real political issue because Opella's products include Doliprane, the best-selling medicine ...

PARIS (Reuters) -The French government needs guarantees from drugmaker Sanofi that production of its popular Doliprane ...

Politicians from across the political spectrum are up in arms over healthcare giant Sanofi's plans to sell France's ...

Politicians and groups from all sides have said the sale of the popular Doliprane drug would be a 'loss of sovereignty'.

Sanofi and CD&R partner to fuel Opella’s ambitions in consumer healthcare Sanofi and CD&R enter exclusive negotiations to transfer a 50% controlling stake in Opella with Sanofi to remain a significant ...

Unions in France are planning a walkout over the planned sale of the pharmaceutical company that makes popular painkiller ...

France is considering taking a stake in Sanofi's Opella arm, said finance minister Antoine Armand, to allay concerns that the ...

France’s Economy Minister has warned that the government could block the sale of a subsidiary of the French pharmaceutical ...

Doliprane, a brand name for paracetomol, is France's most popular medicine and has become part of the social fabric of the ...

France will take a stake in Sanofi’s Opella through the Public Investment Bank, or BPI, finance minister Antoine Armand said on Sunday, confirming an information from Le Figaro ...

PARIS, Oct 14 (Reuters) - The French government needs guarantees from drugmaker Sanofi (SASY.PA), opens new tab that production of its popular Doliprane painkiller will stay in France to allow the ...